Mortality attributable to hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Antithrombin III plus heparin changes mortality attributable to hepatic veno‐occlusive disease ( compared with heparin alone (very low certainty).
1 finding from 1 review
Quality of life · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of adverse events ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Antithrombin III plus heparin changes frequency of adverse events ( compared with heparin alone (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality (subgroup analysis on bias risk) · critically ill participants
The intervention showed no clear difference in mortality (subgroup analysis on bias risk) (moderate certainty).
1 finding from 1 review
Intervention not reported
Bleeding events · critically ill participants
The intervention probably leads to higher bleeding events (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of respiratory failure not present at admission · critically ill participants
The intervention showed no clear difference in incidence of respiratory failure not present at admission (moderate certainty).
1 finding from 1 review
Intervention not reported
Duration of mechanical ventilation · critically ill participants
1 finding from 1 review
Intervention not reported
Length of stay in hospital · critically ill participants
1 finding from 1 review
Intervention not reported
Mean length of stay in ICU · critically ill participants
1 finding from 1 review
Intervention not reported
Overall mortality among patients with severe sepsis & DIC · critically ill participants
It is very uncertain whether the intervention changes overall mortality among patients with severe sepsis & DIC (very low certainty).
1 finding from 1 review